Pregnancy in Inflammatory Arthritis: What Your Patients Need to Know
Megan Clowse, MD, MPH, discusses 2 studies that examine reproductive health concerns in women with inflammatory rheumatic diseases.
Megan Clowse, MD, MPH, discusses 2 studies that examine reproductive health concerns in women with inflammatory rheumatic diseases.
Allan Gibofsky, MD, discusses inhibition of the Wnt pathway and its potential benefits for the treatment of osteoarthritis.
This suggests to us that, as is the standard now, when we use an anabolic agent, we can add in an antiresorptive such as alendronate, and see continued sustained reduction in fracture risk.
Virginia Pascual, MD, discusses precision medicine for rheumatic diseases.
Machelle Manuel, PhD, discusses further gout treatment options to consider when target serum urate levels are not attained.
Patients with scleroderma-associated isolated pulmonary arterial hypertension (SSc-PAH) have a slightly higher mortality risk than patients SSc-PAH with concomitant interstitial lung disease.
Results from the largest prospective study of rituximab use in patients with relapsing ANCA-associated vasculitis show that 91.2% of participants achieved remission.
Rheumatology specialists should be aware of the clinical features of SSc-PAH, as well as the tools available to facilitate a prompt, accurate diagnosis.
Low vitamin D is linked with later total organ and renal damage in patients with SLE.
Opioids and SSRIs are linked to an increased risk of osteoporotic fractures in RA patients.